|
BTBD9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.55540000004828E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.3001000000189E-06 |
| Normal-vs-Stage2 |
1.616030E-01 |
| Normal-vs-Stage3 |
5.598200E-03 |
| Normal-vs-Stage4 |
1.19139999998907E-06 |
| Stage1-vs-Stage2 |
4.043400E-01 |
| Stage1-vs-Stage3 |
9.864400E-01 |
| Stage1-vs-Stage4 |
5.658000E-02 |
| Stage2-vs-Stage3 |
4.644200E-01 |
| Stage2-vs-Stage4 |
6.321600E-02 |
| Stage3-vs-Stage4 |
1.317200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.47179999998581E-06 |
| Normal-vs-AfricanAmerican |
5.180100E-03 |
| Normal-vs-Asian |
7.73280000000431E-05 |
| Caucasian-vs-AfricanAmerican |
2.368800E-01 |
| Caucasian-vs-Asian |
1.621380E-01 |
| AfricanAmerican-vs-Asian |
1.023970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.99269999576902E-08 |
| Normal-vs-Female |
8.943800E-02 |
| Male-vs-Female |
1.823240E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.138170E-03 |
| Normal-vs-Extreme_Weight |
2.17600000240736E-08 |
| Normal-vs-Obese |
1.507770E-02 |
| Normal-vs-Extreme_Obese |
1.579970E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.897600E-01 |
| Normal_Weight-vs-Obese |
2.936000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.746800E-01 |
| Extreme_Weight-vs-Obese |
1.181890E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.977900E-02 |
| Obese-vs-Extreme_Obese |
7.928200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.860000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.80870000000755E-05 |
| Normal-vs-Age(61-80Yrs) |
3.42970000000165E-06 |
| Normal-vs-Age(81-100Yrs) |
1.82419999994465E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.568000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.821200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.673500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.197400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.971700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.170420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.15879999999613E-05 |
| Normal-VS-Type2 PRCC |
7.583300E-04 |
| Normal-VS-KIRP CIMP |
3.954000E-01 |
| Normal-VS-Unclassified PRCC |
1.338260E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.522600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.349200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.341800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.204800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.087000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.991400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.42320000007246E-07 |
| Normal-vs-N1 |
3.166200E-02 |
| Normal-vs-N2 |
7.150200E-04 |
| N0-vs-N1 |
3.387400E-01 |
| N0-vs-N2 |
5.717200E-01 |
| N1-vs-N2 |
7.684200E-02 |
|
|
